162 related articles for article (PubMed ID: 23291037)
1. Study of the recrystallization in coated pellets - effect of coating on API crystallinity.
Nikowitz K; Pintye-Hódi K; Regdon G
Eur J Pharm Sci; 2013 Feb; 48(3):563-71. PubMed ID: 23291037
[TBL] [Abstract][Full Text] [Related]
2. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
3. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
4. Enhanced oral bioavailability of novel mucoadhesive pellets containing valsartan prepared by a dry powder-coating technique.
Cao QR; Liu Y; Xu WJ; Lee BJ; Yang M; Cui JH
Int J Pharm; 2012 Sep; 434(1-2):325-33. PubMed ID: 22688251
[TBL] [Abstract][Full Text] [Related]
5. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical characterization of felodipine-kollidon VA64 amorphous solid dispersions prepared by hot-melt extrusion.
Song Y; Wang L; Yang P; Wenslow RM; Tan B; Zhang H; Deng Z
J Pharm Sci; 2013 Jun; 102(6):1915-1923. PubMed ID: 23580396
[TBL] [Abstract][Full Text] [Related]
7. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
8. Differential scanning calorimetry and surface morphology studies on coated pellets using aqueous dispersions.
Nisar-ur-Rahman ; K H Y; Jia Woei W; Khan NA
Pak J Pharm Sci; 2005 Apr; 18(2):19-23. PubMed ID: 16431393
[TBL] [Abstract][Full Text] [Related]
9. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
10. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
Sauer D; McGinity J
Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
[TBL] [Abstract][Full Text] [Related]
11. An improvement in physicochemical properties of carvedilol through spherically agglomerated solid dispersions with PVP K30.
Tapas A; Kawtikwar P; Sakarkar D
Acta Pol Pharm; 2012; 69(2):299-308. PubMed ID: 22568045
[TBL] [Abstract][Full Text] [Related]
12. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms.
Tiţa B; Fuliaş A; Bandur G; Marian E; Tiţa D
J Pharm Biomed Anal; 2011 Sep; 56(2):221-7. PubMed ID: 21665404
[TBL] [Abstract][Full Text] [Related]
13. Enhanced dissolution, stability and physicochemical characterization of ATRA/2-hydroxypropyl-β-cyclodextrin inclusion complex pellets prepared by fluid-bed coating technique.
Chen Z; Lu Y; Qi J; Wu W
Pharm Dev Technol; 2013 Feb; 18(1):130-6. PubMed ID: 22304703
[TBL] [Abstract][Full Text] [Related]
14. The Physicochemical Investigation of 17β-Estradiol Crystalline Prepared by In Situ pH-Dependent Solubility Technique with Polyvinylpyrrolidone.
Xiong H; Fu J; Sun H; Wang E; Ding Y; Ren G; Jing Q; Ren F
AAPS PharmSciTech; 2017 Nov; 18(8):2889-2897. PubMed ID: 28424978
[TBL] [Abstract][Full Text] [Related]
15. Physico-chemical solid-state characterization of omeprazole sodium: thermal, spectroscopic and crystallinity studies.
Murakami FS; Lang KL; Mendes C; Cruz AP; Carvalho Filho MA; Silva MA
J Pharm Biomed Anal; 2009 Jan; 49(1):72-80. PubMed ID: 19038514
[TBL] [Abstract][Full Text] [Related]
16. Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices.
Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Drug Dev Ind Pharm; 2010 Feb; 36(2):218-26. PubMed ID: 19877992
[TBL] [Abstract][Full Text] [Related]
17. Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.
Aucamp M; Milne M; Liebenberg W
AAPS PharmSciTech; 2016 Oct; 17(5):1100-9. PubMed ID: 26531745
[TBL] [Abstract][Full Text] [Related]
18. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
19. Water-mediated solid-state transformation of a polymorphic drug during aqueous-based drug-layer coating of pellets.
Lust A; Lakio S; Vintsevits J; Kozlova J; Veski P; Heinämäki J; Kogermann K
Int J Pharm; 2013 Nov; 456(1):41-8. PubMed ID: 23994016
[TBL] [Abstract][Full Text] [Related]
20. Physical characteristics and chemical degradation of amorphous quinapril hydrochloride.
Guo Y; Byrn SR; Zografi G
J Pharm Sci; 2000 Jan; 89(1):128-43. PubMed ID: 10664545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
